Trials / Unknown
UnknownNCT02154854
Prospective Study to Measure Vascular Parameters (Ancillary Study of ADEQUATE)
Effect of Advagraf on Arterial Stiffness and on Vascular Fibrosis Plasma Markers on de Novo Renal Transplant Patients
- Status
- Unknown
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 104 (estimated)
- Sponsor
- University Hospital, Tours · Academic / Other
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to compare parallel-group effects between 4 months and 12 months post-transplantation 2 values of target residual concentrations of Advagraf on vascular parameters in de novo renal transplant patients.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Tacrolimus targeted half-dose | |
| DRUG | Tacrolimus targeted plain dose |
Timeline
- Start date
- 2013-07-01
- Primary completion
- 2015-03-01
- Completion
- 2015-03-01
- First posted
- 2014-06-03
- Last updated
- 2014-06-03
Locations
11 sites across 1 country: France
Source: ClinicalTrials.gov record NCT02154854. Inclusion in this directory is not an endorsement.